ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery.
ALLOX has raised $10.5M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
ALLOX's investors include Asabys Partners, CDTI Innovación's INNVIERTE program, ICF - Institut Català de Finances.
ALLOX is headquartered in Barcelona, Spain.
ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery.
ALLOX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ALLOX — Funding & Investors." VCBacked, October 29, 2026, https://www.vcbacked.co/company/allox. Accessed November 2, 2026.
VCBacked. (2026). ALLOX — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/allox
{{cite web |title=ALLOX — Funding & Investors |url=https://www.vcbacked.co/company/allox |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ALLOX? Request a listing update